A standard knee replacement uses bone cement to secure the components of the implant. But now, an increasing number of orthopedic surgeons are opting for cementless knee replacement procedures for their patients, as the implant could potentially last much longer, compared to conventional cemented knee replacement procedure.
Zimmer Biomet Holdings Inc. (ZBH), a global medical technology company, recently made an addition to its cementless knee replacement portfolio - gaining FDA clearance for Persona OsseoTi Keel Tibia on Nov.21, 2022.
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com